The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $67.10

Today's change0.00 0.00%
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $67.10

Today's change0.00 0.00%
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.

Charles River Laboratories International Inc closed at (U.S.)$67.10.

Over the last five days, shares have lost 10.38% and are down 16.53% for the last year to date. This security has outperformed the S&P 500 by 6.31% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $67.10
  • High--
  • Low--
  • Bid / Ask(U.S.) $63.65 / (U.S.) $70.53
  • YTD % change-16.53%
  • Volume0
  • Average volume (10-day)720,860
  • Average volume (1-month)723,451
  • Average volume (3-month)547,693
  • 52-week range(U.S.) $59.99 to (U.S.) $84.69
  • Beta1.34
  • Trailing P/E21.92×
  • P/E 1 year forward18.07×
  • Forward PEG1.92×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.06
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.00%

Based on its net profit margin of 11.00%, Charles River Laboratories International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 26, 201509/26/2015Jun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014
Revenue349340320330
Total other revenue--------
Total revenue349340320330
Gross profit138133120120
Total cost of revenue211207201210
Total operating expense294284277289
Selling / general / administrative76717170
Research & development--------
Depreciation / amortization6657
Interest expense (income), net operating--------
Unusual expense (income)--112
Other operating expenses, total--------
Operating income55564341
Interest income (expense), net non-operating-4-4-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax53603240
Income after tax38493229
Income tax, total1511012
Net income37493227
Total adjustments to net income--------
Net income before extra. items37493228
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items37493228
Inc. avail. to common incl. extra. items37493227
Diluted net income37493227
Dilution adjustment----00
Diluted weighted average shares47484848
Diluted EPS excluding extraordinary itemsvalue per share0.791.020.660.59
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.791.030.681.25